Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9361-9368

  Watanabe, Tokiko ^a,b   Imai, Masaki ^a   Watanabe, Shinji ^a,b   Shinya, Kyoko ^c   Hatta, Masato ^a   Li, Chengjun ^a   Neumann, Gabriele ^a   Ozawa, Makoto ^a   Hanson, Anthony ^a   Zhong, Gongxun ^a   Fukuyama, Satoshi ^b   Kawakami, Eiryo ^b   Simmons, Heather A ^d   Schenkman, Daniel ^a,d   Brunner, Kevin ^d   Capuano III, Saverio V ^d   Weinfurter, Jason T ^a,d   Kilander, Anette ^e   Dudman, Susanne G ^e   Suresh, M ^a   Hungnes, Olav ^e   Friedrich, Thomas C ^a,d   Kawaoka, Yoshihiro ^a,b,c,f   more..

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d UNIVERSITY OF WISCONSIN   (United States)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ALPHA; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FERRET; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; INTERSTITIAL PNEUMONIA; MACACA FASCICULARIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BINDING; VIRAL CLEARANCE; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS PNEUMONIA; VIRUS REPLICATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; FEMALE; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MACACA; MOLECULAR SEQUENCE DATA; NORWAY; PANDEMICS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; MUSTELA; ORTHOMYXOVIRIDAE; PRIMATES;

EID: 84866177978     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01214-12     Document Type: Article

References (38)

1. Baskin CR, et al. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106: 3455-3460.
2. Bautista E, et al. 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362: 1708-1719.
3. Blixt O, et al. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U. S. A. 101: 17033-17038.
4. Christman MC, Kedwaii A, Xu J, Donis RO, Lu G. 2011. Pandemic (H1N1) 2009 virus revisited: an evolutionary retrospective. Infect. Genet. Evol. 11: 803-811.
5. Chutinimitkul S, et al. 2010. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J. Virol. 84: 11802-11813.
6. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3: 1414-1421.
7. Fereidouni SR, Beer M, Vahlenkamp T, Starick E. 2009. Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March-September 2009. Euro Surveill. 14(46):pii=19409.
8. Gabriel G, Herwig A, Klenk HD. 2008. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog. 4:e11. doi:10.1371/journal.ppat.0040011.
9. Garten RJ, et al. 2009. Antigenic and genetic characteristics of swineorigin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
10. Gibbs AJ, Armstrong JS, Downie JC. 2009. From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge? Virol. J. 6:207.
11. Hatta M, Gao P, Halfmann P, Kawaoka Y. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 293: 1840-1842.
12. Herfst S, et al. 2010. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet. Pathol. 47: 1040-1047.
13. Itoh Y, et al. 2009. In vitro and in vivo characterization of new swineorigin H1N1 influenza viruses. Nature. 460: 1021-1025.
14. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. 2008. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 105: 4381-4386.
15. Katz JM, Wang M, Webster RG. 1990. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64: 1808-1811.
16. Kawaoka Y, Webster RG. 1988. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 85: 324-328.
17. Kobasa D, et al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 445: 319-323.
18. Li Z, et al. 2005. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 79: 12058-12064.
19. Liu Y, et al. 2010. Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza. J. Virol. 84: 12069-12074.
20. Matrosovich M, et al. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74: 8502-8512.
21. Matrosovich MN, Gambaryan AS, Klenk H-D. 2008. Receptor specificity of influenza viruses and its alteration during interspecies transmission, p134-155. In Klenk H-D, Matrosovich MN, Stech J (ed), Avian influenza, vol 27. Karger, Basel, Switzerland.
22. Mura M, dos Santos CC, Stewart D, Liu M. 2004. Vascular endothelial growth factor and related molecules in acute lung injury. J. Appl. Physiol. 97: 1605-1617.
23. Neumann G, et al. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96: 9345-9350.
24. Obenauer JC, et al. 2006. Large-scale sequence analysis of avian influenza isolates. Science. 311: 1576-1580.
25. Ozawa M, et al. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J. Virol. 81: 30-41.
26. Park JW, et al. 2004. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am. J. Respir. Cell Mol. Biol. 30: 830-836.
27. Rimmelzwaan GF, et al. 2001. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75: 6687-6691.
28. Safronetz D, et al. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85: 1214-1223.
29. Seo SH, Hoffmann E, Webster RG. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8: 950-954.
30. Shiino T, et al. 2010. Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 5:e11057. doi:10.1371/journal.pone.0011057.
31. Shinya K, et al. 2006. Avian flu: influenza virus receptors in the human airway. Nature. 440: 435-436.
32. Smith GJ, et al. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 459: 1122-1125.
33. Subbarao EK, London W, Murphy BR. 1993. A single amino acid in the PB2 gene of influenzaAvirus is a determinant of host range. J. Virol. 67: 1761-1764.
34. Trifonov V, Khiabanian H, Rabadan R. 2009. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N. Engl. J. Med. 361: 115-119.
35. Watanabe T, et al. 2011. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J. Virol. 85: 13195-13203.
36. Weinfurter JT, et al. 2011. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog. 7:e1002381. doi:10.1371/journal.ppat.1002381.
37. Xu L, et al. 2010. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemicA(H1N1) influenza viruses in vitro and in vivo. Virol. J. 7:325.
38. Yang H, Carney P, Stevens J. 2010. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2:RRN1152. doi:10.1371/currents.RRN1152.